NextCure
NXTC
88 hedge funds and large institutions have $434M invested in NextCure in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 41 increasing their positions, 16 reducing their positions, and 15 closing their positions.
156% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 16
40% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 15
7% more funds holding
Funds holding: 82 → 88 (+6)
0.01% less ownership
Funds ownership: 6.14% → 6.13% (-0.01%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
42% less capital invested
Capital invested by funds: $751M → $434M (-$317M)
65% less call options, than puts
Call options by funds: $354K | Put options by funds: $1.02M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$10.3M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$8.92M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$4.37M |
| 4 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$4.23M |
| 5 |
Two Sigma Investments
New York
|
+$3.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$13.2M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$11.8M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$9.94M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$5.39M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.24M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
BAMCO Inc
New York
| – | -$28K | -64 | Closed |
|
|
PA
102
Parallel Advisors
San Francisco,
California
| – | -$8K | -20 | Closed |
|
NXTC Hedge Fund Activity: Q2 2020 in Review
88 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q2 2020, worth a combined $434M — down 42% from $751M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NXTC positions and 15 closed out — a net gain of 6 holders — while 41 added to existing stakes and 16 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $10.3M. The largest seller was HHLR Advisors, cutting an estimated $13.2M.
- 88 institutional investors held NextCure (NXTC) as of Q2 2020, up from 82 in Q1 2020.
- Funds reported $434M of NextCure stock for Q2 2020, down 42% quarter-over-quarter.
- 21 funds opened new NextCure positions in Q2 2020 and 15 closed out, a net change of +6 holders.
- The largest NextCure buyer in Q2 2020 was Morgan Stanley, an estimated $10.3M added.
- The largest NextCure seller in Q2 2020 was HHLR Advisors, an estimated $13.2M sold.
Based on aggregated 13F filings for Q2 2020.